Ciliatech are delighted to announce the appointment of Coen Van Der Steur as International Business Development Consultant, joining the company to support its global commercial organisation and reporting directly to Sahil Syed, VP Sales & Marketing.
In his new role, Coen will lead business development activities across the Middle East, strengthen relationships with distributors, surgeons and key opinion leaders, and support the commercial expansion of Ciliatech’s innovative glaucoma technologies throughout the region. His primary focus will include Bahrain, UAE, Qatar, Saudi Arabia, Egypt, Iraq, Iran, Jordan, Syria, Lebanon, Israel, Kuwait, Oman and Turkey. Drawing on his extensive industry expertise and international leadership experience, he will play a key role in supporting the successful commercialisation of the Intercil® Uveal Spacer.
Prior to joining Ciliatech, Coen gained more than 34 years of experience in the pharmaceutical and medical device industries, specialising in surgical ophthalmology, minimally invasive glaucoma surgery (MIGS), international business development and commercial leadership. Following his early career as a Medical Adviser and International Product Manager, he spent 11 years at Bausch & Lomb as Surgical Ophthalmology Business Unit Manager for Central and Eastern Europe, Greece, Turkey, the Middle East and Africa, where he successfully increased regional sales from $9 million to $25 million. He later spent ten years at D.O.R.C., holding several Director-level positions with responsibility for commercial operations across the Middle East, Africa, India and Asia Pacific, managing annual sales portfolios of approximately €36 million. Most recently, he served as General Manager for the Middle East Region at Glaukos Corporation, where he established the regional distribution network from the ground up, worked closely with Legal, Regulatory Affairs and Marketing teams to build the regional infrastructure, secured insurance coverage for the iStent®, developed partnerships with five key distributors and built a strong network of KOL across both glaucoma and keratoconus.
Coen’s appointment further strengthens Ciliatech’s international expansion strategy as the company prepares for the commercial launch of the Intercil® Uveal Spacer. His expertise will support the continued development of the Middle East region, where he will focus on strengthening Ciliatech’s presence across Bahrain, UAE, Saudi Arabia, Qatar, Egypt, Iraq, Iran, Jordan, Syria, Lebanon, Israel, Kuwait, Oman and Turkey.
Coen officially joined Ciliatech on 3rd June 2025.
